Lv11
58 积分 2025-07-29 加入
Early pre-existing anti-drug antibody screening in biotherapeutic development: a cross-company perspective
5小时前
已完结
Single domain camel antibodies: current status
9天前
已完结
Nanobodies: Natural Single-Domain Antibodies
12天前
已完结
MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity
27天前
已完结
Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity
27天前
已完结
Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity
1个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
2个月前
已完结
Structural and Functional Characterization of Disulfide Bond Isomers of Therapeutic Immunoglobulin G2 Antibody
3个月前
已完结
Development of Different Analysis Platforms with LC−MS for Pharmacokinetic Studies of Protein Drugs
5个月前
已完结
A Novel and Cost Effective Method of Removing Excess Albumin from Plasma/Serum Samples and Its Impacts on LC-MS/MS Bioanalysis of Therapeutic Proteins
5个月前
已完结
皖公网安备34019202002308
